Grade 2 Meningioma — Trials

Grade 2 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01024907	Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	completed	Phase 1 / Phase 2	23	Abramson Cancer Center at Penn MedicineOTHER	1	Dec 10, 2020	clinicaltrials
NCT00045110	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma	completed	Phase 1 / Phase 2	136	National Cancer Institute (NCI)NIH	1	Aug 17, 2017	clinicaltrials
NCT00326664	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Mar 7, 2016	clinicaltrials
NCT01119599	RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Data updated 22 days agoSource updated Dec 10, 2020source: clinicaltrials